Literature DB >> 7545114

Macrophages, but not dendritic cells, present collagen to T cells.

E Michaëlsson1, M Holmdahl, A Engström, H Burkhardt, A Scheynius, R Holmdahl.   

Abstract

Dendritic cells, such as epidermal Langerhans cells, play a crucial role for the antigen-specific priming of T cells. We have addressed the question whether dendritic cells present collagen, a major protein component in tissues through which dendritic cells migrate, i.e. the basement membrane, dermis, and synovial tissue. Langerhans cells, spleen cells and peritoneal macrophages were compared for antigen-presenting capacity using a panel of mouse T cell hybridomas reactive with different determinants on type II collagen, myelin basic protein, ovalbumin and pepsin. Langerhans cells did not present any of the type II collagen determinants, unless the antigen was administered as a 15-mer peptide, but did present myelin basic protein, ovalbumin and pepsin. Spleen cells and peritoneal macrophages, in contrast, presented all type II collagen determinants. This biased antigen presentation was also observed when Langerhans cells were pulsed with antigen in vivo. The inability to present type II collagen is related to the collagen sequence as such, since both native type II collagen, type II collagen alpha chains, as well as a type II collagen determinant incorporated in type I collagen, were not presented by Langerhans cells. In addition, granulocyte/macrophage colony-stimulating factor-expanded blood dendritic cells displayed the same biased antigen presentation, suggesting that the inability to present collagen is not restricted to dendritic cells localized in epidermis. B cell-deficient mice could prime a type II collagen-reactive T cell response, thus excluding B cells as obligatory antigen-presenting cells for the priming of collagen-reactive T cells. We suggest that neither Langerhans cells nor B cells, but macrophages are the primary antigen-presenting cells in the immune response towards type II collagen.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7545114     DOI: 10.1002/eji.1830250818

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  16 in total

1.  Antigen presentation of Type II collagen in rats.

Authors:  B Catchpole; N A Staines; A S Hamblin
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

2.  Granulocyte-macrophage colony stimulating factor exacerbates collagen induced arthritis in mice.

Authors:  I K Campbell; A Bendele; D A Smith; J A Hamilton
Journal:  Ann Rheum Dis       Date:  1997-06       Impact factor: 19.103

3.  JNK1, but not JNK2, is required in two mechanistically distinct models of inflammatory arthritis.

Authors:  Katja Denninger; Susanne Rasmussen; Jeppe Madura Larsen; Catrine Orskov; Steen Seier Poulsen; Poul Sørensen; Jan Pravsgaard Christensen; Harald Illges; Niels Odum; Tord Labuda
Journal:  Am J Pathol       Date:  2011-08-11       Impact factor: 4.307

4.  Distinct roles for the NF-kappaB1 (p50) and c-Rel transcription factors in inflammatory arthritis.

Authors:  I K Campbell; S Gerondakis; K O'Donnell; I P Wicks
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

5.  Systemic versus cartilage-specific expression of a type II collagen-specific T-cell epitope determines the level of tolerance and susceptibility to arthritis.

Authors:  V Malmström; E Michaëlsson; H Burkhardt; R Mattsson; E Vuorio; R Holmdahl
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

6.  Cystatin C influences the autoimmune but not inflammatory response to cartilage type II collagen leading to chronic arthritis development.

Authors:  Alexandra Bäcklund; Meirav Holmdahl; Ragnar Mattsson; Katarina Håkansson; Veronica Lindström; Kutty Selva Nandakumar; Anders Grubb; Rikard Holmdahl
Journal:  Arthritis Res Ther       Date:  2011-03-28       Impact factor: 5.156

7.  Nanostructured, self-assembling peptide K5 blocks TNF-α and PGE₂ production by suppression of the AP-1/p38 pathway.

Authors:  Woo Seok Yang; Yung Chul Park; Ji Hye Kim; Hye Ri Kim; Tao Yu; Se Eun Byeon; Larry D Unsworth; Jaehwi Lee; Jae Youl Cho
Journal:  Mediators Inflamm       Date:  2012-01-24       Impact factor: 4.711

Review 8.  Cells of the synovium in rheumatoid arthritis. Dendritic cells.

Authors:  Viviana Lutzky; Suad Hannawi; Ranjeny Thomas
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

9.  Systemic administration of tolerogenic dendritic cells ameliorates murine inflammatory arthritis.

Authors:  Louise J Healy; Helen L Collins; Stephen J Thompson
Journal:  Open Rheumatol J       Date:  2008-12-03

10.  p38/AP-1 pathway in lipopolysaccharide-induced inflammatory responses is negatively modulated by electrical stimulation.

Authors:  Deok Jeong; Jaehwi Lee; Young-Su Yi; Yanyan Yang; Kyoung Won Kim; Jae Youl Cho
Journal:  Mediators Inflamm       Date:  2013-04-14       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.